Kyle A Blum
Overview
Explore the profile of Kyle A Blum including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
622
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Gupta S, Cheville J, Jungbluth A, Zhang Y, Zhang L, Chen Y, et al.
Mod Pathol
. 2019 Apr;
32(9):1344-1358.
PMID: 30996253
Amplifications of JAK2, PD-L1, and PD-L2 at 9p24.1 lead to constitutive expression of PD-L1. This, coupled with JAK2-activation dependent upregulation of PD-L1 and adaptive/induced expression leads to higher tumor PD-L1...
32.
Capodice J, Parkhomenko E, Tran T, Thai J, Blum K, Chandhoke R, et al.
J Endourol
. 2019 Jan;
33(3):194-200.
PMID: 30693806
Introduction: Percutaneous nephrolithotomy (PCNL) is the gold standard procedure for large renal calculi but postoperative (PO) pain remains a concern. Modifications of the PCNL technique and intraoperative and PO strategies...
33.
Gul Z, Blum K, Paulucci D, Abaza R, Eun D, Bhandari A, et al.
J Robot Surg
. 2018 Oct;
13(3):423-428.
PMID: 30315391
To evaluate peri- and post-operative outcomes after robotic partial nephrectomy (RPN) in patients with a solitary kidney. A multi-institutional database of 1868 patients was used to identify 35 patients with...
34.
Kaldany A, Blum K, Paulucci D, Beksac A, Jayaratna I, Sfakianos J, et al.
Urol Oncol
. 2018 Jun;
36(8):363.e1-363.e6.
PMID: 29884343
Introduction: Enrollment of a representative study population permits generalizable and reliable results for clinical trials. We sought to evaluate whether patients enrolled in trials for advanced renal cell carcinoma (RCC)...
35.
Mendonca S, Sanchez A, Blum K, Ghanaat M, Kashan M, Benfante N, et al.
J Surg Oncol
. 2018 Jun;
117(8):1716-1720.
PMID: 29878354
Background And Objectives: Prior small studies have reported a possible association between renal cell carcinoma (RCC) and gastrointestinal stromal tumors (GISTs). In the largest known series, our objective was to...
36.
Blum K, Parkhomenko E, Thai J, Tran T, Gupta M
World J Urol
. 2018 Apr;
36(9):1461-1467.
PMID: 29616297
Purpose: Percutaneous nephrolithotomy (PCNL) is the preferred surgical treatment for staghorn stones. Two approaches are commonly employed to gain access into the collecting system which consists of either an upper...
37.
John N, Blum K, Hakimi A
Urol Oncol
. 2018 Apr;
37(3):187-192.
PMID: 29602639
Lymph node metastasis in renal cell cancer (RCC) portends an extremely poor prognosis. Despite proven staging benefit, the therapeutic value of lymph node dissection in RCC remains questionable. The only...
38.
Kashan M, Ghanaat M, Hotker A, Duzgol C, Sanchez A, DiNatale R, et al.
J Urol
. 2018 Mar;
200(2):275-282.
PMID: 29496470
Purpose: We evaluated the outcomes of surgical intervention and active surveillance in patients diagnosed with cystic renal cell carcinoma at our hypothesized radiological cutoff of greater than 50% cystic. Materials...
39.
Becerra M, Reznik E, Redzematovic A, Tennenbaum D, Kashan M, Ghanaat M, et al.
Eur Urol Focus
. 2017 Oct;
4(6):986-994.
PMID: 29066084
Background: Next-generation sequencing (NGS) studies of matched pairs of primary and metastatic tumors in renal cell carcinoma (RCC) have been limited to small cohorts. Objective: To evaluate the discordance in...
40.
Beksac A, Paulucci D, Blum K, Yadav S, Sfakianos J, Badani K
Urol Oncol
. 2017 May;
35(8):507-515.
PMID: 28551412
Introduction: In recent years, molecular characterization of renal cell carcinoma has facilitated the identification of driver genes, specific molecular pathways, and characterization of the tumor microenvironment, which has led to...